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Abstract 
Objective: Current global trends on natural therapeutics suggest an increasing market interest toward the use and 
discovery of new plant-derived therapeutic compounds, often referred to as traditional medicine (TM). The Cannabis 
industry is currently one such focal area receiving attention, owing to the occurrence of phytocannabinoids (pCBs) 
which have shown promise in health-promotion and disease prevention. However, the occurrence of pCBs in other 
plant species are often overlooked and rarely studied. Leonotis leonurus (L.) R. Br. is endemic to South Africa with a 
rich history of use in TM practices amongst indigenous people and, has been recorded to induce mild psychoactive 
effects akin to Cannabis. While the leaves have been well-reported to contain therapeutic phytochemicals, little infor-
mation exists on the flowers. Consequently, as part of a larger research venture, we targeted the flowers of L. leonurus 
for the identification of potential pCB or pCB-like compounds.
Results: Flower extracts were separated and analyzed using high performance thin layer chromatography (HPTLC). 
A single pCB candidate was isolated from HPTLC plates and, using liquid chromatography coupled to tandem mass 
spectrometry (LC–MS/MS), we could successfully group this compound as a fatty amide and tentatively identified as 
7,10,13,16-Docosatetraenoylethanolamine (adrenoyl-EA), a known bioactive compound.
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Introduction
Increasing interest from developed economies in the 
use of TMs has created the second largest global thera-
peutics market [1, 2]. The medicinal Cannabis industry 
is currently one such focal area, largely because of the 
occurrence of phytocannabinoids (pCBs). As part of a 
unique class of phytochemicals that interact with the 
human endocannabinoid system (ECS), the use of pCBs 
as therapeutics holds promise in the treatment of numer-
ous chronic diseases [3–8]. However, many countries still 
abide by strict regulatory laws pertaining to the commer-
cial growth of Cannabis and, consequently research into 
pharmacologically relevant products has until recently, 
been relatively protracted. Since the discovery of pCBs, 
similar compounds (pCB-like) have been reported in 
several plant species, beyond Cannabis, that are com-
monly used in TM practices [9]. The growing interest in 
the use of TMs enabled an opportunity for the discovery 
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non-medicinal plants for the development of natural 
therapeutics.
The use of the ‘wild cannabis’ plant, L. leonurus (L.) 
R. Br., endemic to South Africa, is commonly reported 
in TM to treat numerous ailments including eczema, 
headaches, hypertension, and chest infections [10, 11]. 
The leaves (when smoked) have been described to elicit 
similar effects to Cannabis, including mild psychoactive 
symptoms, as well as the capacity to alleviate anxiety 
and induce calming effects [10, 12]. Despite the amount 
of research available on the leaves, little to no informa-
tion exists on the medicinal properties of the flowers 
of this plant. Furthermore, the occurrence of pCBs or 
pCB-like compounds has never been reported. In this 
research note, we report on the tentative identification of 
a pCB-like compound (like adrenoyl-EA) in the flowers 





L. leonurus var. albiflora Benth. seeds (white flower vari-
ety) were obtained from a commercial seed supplier 
(Seeds for Africa, South Africa) and grown on a residen-
tial property at the Bottom Road Sanctuary, Zeekoevlei, 
Western Cape Province, South Africa (GPS coordinates: 
−34.057951, 18.499391). Flower samples were harvested 
at mature stage (Fig. 1, photo courtesy of Dr B Loedolff) 
and immediately stored at −20 °C.
Whole flower metabolite extraction
Flowers were lyophilized (20  h; 100 mTorr, −60  °C) 
and ground to a fine powder using a pestle and mortar. 
Metabolites were extracted from flower material (50 mg) 
as previously described [13, 14], evaporated, and the 
resin reconstituted in 200 μL  ddH2O, calibrating the 
extracts to 0.50 mg/μL.
Phytocannabinoid screening and isolation using HPTLC
Phytocannabinoid screening was performed on 
10 × 20  cm glass-back plates pre-coated with 0.25  mm 
silicagel 60 (REF 811213, Macherey–Nagel, Germany). 
Flower derived-extracts (0.50 mg/μL) were applied to the 
plates in 2 μL increments and allowed to dry completely 
before placement into a glass chromatography chamber 
(Camag, Switzerland), pre-conditioned with the mobile 
phase, chloroform:methanol (9:1; 30 min). Subsequently, 
the chromatogram was developed in the dark using fast 
blue B reagent (0.1% w/v; dissolved in 1  mM NaOH). 
Based on  Rf ranges (comparative to the upper  Rf values 
representing the less polar range of pCBs from Cannabis, 
under the same chromatographic conditions [15]) and 
change in colour [16]), a single, red–orange compound of 
interest was scraped from the preparative HPTLC plate 
and resuspended in 50% (v/v) methanol, prior to tandem 
mass spectrometry (LC–MS/MS) analyses.
Tandem mass spectrometry (LC–MS/MS) analyses
LC–MS/MS analyses were performed, as previously 
described [14], with a Waters Synapt G2 quadrupole 
time-of-flight mass spectrometer (Waters Corporation, 
Milford, MA, USA) equipped with a Waters Acquity 
UPLC. Samples were separated on a Waters UPLC BEH 
C18 column (2.1 ×  100  mm; 1.7  μm) at a flow rate of 
0.25  ml/min at 55  °C. Solvent A consisted of 0.1% (v/v) 
formic acid in water and solvent B was 0.1% (v/v) formic 
acid in acetonitrile. The mobile phase gradient was ini-
tiated at 100% solvent A for 1 min and linearly reduced 
to 28% solvent A over 22 min. Subsequently, the mobile 
phase was changed to 40% solvent B over 8 min followed 
by a 1 min wash step in 100% solvent B before the column 
was re-equilibrated to the initial conditions for 4  min. 
Electrospray ionization was applied, and samples were 
analysed in a negative mode run and a positive mode 
run. Data was acquired in  MSE mode, which consists of 
a high collision energy scan range of m/z 125–1500 and 
Fig. 1 HPTLC phytochemical profile of Leonotis leonurus var. albiflora 
Benth. whole flower extract. a L. leonurus var. albiflora Benth. white 
flower phenotypic appearance (Photo courtesy of Dr B Loedolff ) and 
b its corresponding acetonitrile (75%) extract, HPTLC phytochemical 
profile. Whole flower metabolite extractions were prepared using 
various extraction solvents and, the acetonitrile (75%) extracts were 
selected for downstream analyses. The phytochemical profile was 
developed fully (mobile phase; chloroform:methanol 9:1, stationary 
phase;  silica60Å) before reagent visualization (0.1% Fast blue B salt 
dissolved in 1 mM NaOH) was applied to reveal potential pCB 
candidates, based solely on an red–orange colour development. 
Compound x (Rf value: 0.55) represents a colorimetric-specific 
pCB-like candidate compound which was selected for further LC–MS/
MS analyses
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a low collision energy scan from m/z 40–1500. The photo 
diode array detector was set to scan from 220–600 nm. 
The capillary voltage was set at 3.5 kV and the collision 
energy either 6  V (low collision energy scan from) or 
30–60  V (high collision energy scan), the cone voltage 
was 15 V, the source temperature 120 °C and the desolva-
tion temperature was 275  °C. The desolvation and cone 
gas (nitrogen) flows were 650 and 50 L/h, respectively. 
Sodium formate was used for calibration and leucine 
encephalin was infused in the background as lock mass 
for accurate mass determinations, where authentic refer-
ence compounds were available. Metabolites were moni-
tored using their deprotonated quasi-molecular ions.
Compounds were tentatively identified using the 
Metabolomics workbench [17]. The database was 
searched, using the m/z mass obtained from total ion 
chromatograms, with parameters set to the negative 
[M-H]− and positive ion [M + H]+ mode, respectively, 
and a mass tolerance of ± 0.5  m/z. Tentative identifica-
tion was based on the experimental mass of the specific 
peaks compared to literature and was carried out in 
conjunction with independent metabolite repositories, 
Metabolomics Workbench, PubChem, and METLIN 
Metabolite and Chemical Entity Database.
Results and discussion
L. leonurus (L.) R. Br. is a drought resistant medicinal 
shrub endemic to South Africa with a bi-annual flowering 
season (high-yielding medicinal crop). Anecdotally it is 
known for eliciting mild psychoactive effects akin to the 
smoking of Cannabis and, has a long-standing history in 
traditional healing practices in South Africa. Some stud-
ies have alluded to its medicinal activities however, these 
have largely focused on the leaves and only a few reports 
have dealt with the flowers [10, 11]. Furthermore, there 
are no reports that describe the occurrence of medici-
nal pCBs from the leaves or the flowers. Since pCBs have 
been proposed as effective TMs for the prevention and/
or treatment of chronic diseases [18–20], identification of 
pCBs (or pCB-like compounds) in plants other than Can-
nabis spp. could present an attractive value proposition to 
complement the emergent Cannabis industry.
Based on its mild Cannabis-like effect when smoked, 
we conducted analyses into the flower-derived phyto-
chemicals and the potential presence of pCB-like com-
pounds in L. leonurus var. albiflora Benth. (Fig.  1a). 
Since extensive phytochemical profiling of the leaves 
have never yielded any pCB-like compounds [10, 11], we 
suspected that such compounds may be present in flow-
ers (akin to Cannabis). Using HPTLC, coupled to fast 
blue B salt as a selective colorimetric detection method 
for pCB compounds [14], we extracted flower metabo-
lites with gradient concentrations (50, 75 and 100%) of 
either methanol or acetonitrile (Additional file 1: Figure 
S1). The fast blue method detects major neutral cannabi-
noids such as tetrahydrocannabinol (THC), cannabidiol 
(CBD), and their cannabinoid acid derivatives THCA and 
CBDA, among other cannabinoids with high sensitivity 
and selectivity [15, 16].
A single, potential pCB-like compound (distinct red–
orange colour,  Rf 0.55; Fig.  1b) was isolated, and its 
identity tentatively determined using LC–MS/MS in 
both positive and negative ionization modes (Fig. 2a, b). 
Mass spectra from whole flower extracts and the isolated 
HPTLC compound were compared (Fig. 2c, d) resulting 
in equivalent retention times and peak masses in both 
negative (RT: 30.78 min; [M−H]− = 374.26) and positive 
(RT: 30.77  min; [M + H]+  = 376.26) ionization mode. 
Further investigation using the international metabolite 
repositories, Metabolomics Workbench, PubChem, and 
METLIN Metabolite and Chemical Entity Database, con-
sistently grouped this compound as a fatty amide with 
tentative identification as 7,10,13,16-Docosatetraenoy-
lethanolamine ([M–H]− = 374.31; [M + H]+  = 376.32; 
neutral m/z = 375.31), also known as adrenoyl-ethanola-
mide (EA). Adrenoyl-EA is a bioactive endocannabinoid 
previously thought to be unique to mammals [21, 22]. 
However, it has recently (and for the first time) been con-
firmed to occur in methanol extracts of the Mashua plant 
(Tropaeolum tuberosum), extensively used in Andean 
folk medicine [23]. Our findings tentatively identify the 
occurrence of a pCB-like compound (predicted to be like 
adrenoyl-EA) in acetonitrile extracts from the flowers of 
L. leonurus var. albiflora Benth.
Adrenoyl-EA is structurally similar to the major endo-
cannabinoid anandamide and functions as an agonist of 
the  CB1 and  TRPV1 receptor proteins, two major recep-
tors of the human ECS [21, 24]. Agonists of these recep-
tors are ideal candidates in a range of therapeutic targets, 
specifically exhibiting anti-inflammatory, neuroprotec-
tive, and anticancer activities, among others [23, 25, 
26]. Within the growing market of TMs, we consider it 
beneficial to identify sustainable, climate resilient plant 
resources (high yielding medicinal crops) that accumu-
late pCBs or PCB-like compounds with the potential for 
therapeutic purposes.
A South African perspective on the development of pCB 
products
It is estimated that the domestic South Africa Cannabis 
market will reach USD $1.8 billion by 2023 however, this 
projection is based on export value only, excluding Can-
nabis-derived pCB products. The value proposition lies 
within the latter, given the therapeutic potential of pCBs 
in chronic disease treatment [23–26]. South African agri-
culture is typified by both large scale mechanized, and 
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smallholder practices and Cannabis cultivation is con-
sidered viable. Although the agricultural experience and 
arable land in South Africa is adequate for the growth 
and export of Cannabis, the irrigation infrastructure and 
required daylight might not be sufficient to sustain the 
production of high quality Cannabis-derived products. 
One of the major predicted hurdles in establishing a sus-
tainable Cannabis industry is the water-intensive meas-
ures required for an efficient pCB yield from Cannabis. If 
one could exploit a water-efficient medicinal crop capa-
ble of producing pCB-like compounds, this would serve 
as an ideal industry alternative into a realm of “smart-
pharming” practices.
As part of a pCB-driven strategy for the development 
of high value TMs, we suggest that the discovery of pCBs 
in endemic South African plants could be highly comple-
mentary to the Cannabis industry, given that these plants 
are adapted to the climatic and water-scarce conditions. 
To our knowledge, we provide the first evidence on the 
presence of the pCB-like compound, adrenoyl-EA, in 
the flowers of L. leonurus var. albiflora Benth. Globally, 
the production of pCBs from these alternative resources 
could benefit the future TM market, particularly in coun-
tries where agriculture is typified by water scarcity.
Limitations
This research note serves to highlight the potential exist-
ence of pCBs or pCB-like compounds within the whole 
flower extract of L. leonurus var. albiflora Benth. HPTLC 
screening indicated the potential existence of several 
Fig. 2 LC–MS/MS spectra of Leonotis leonurus var. albiflora Benth. whole flower extract, targeting the cannabinoid occurrence in flowers. LC–MS/
MS spectra of white L. leonurus var. albiflora Benth. whole flower extract in negative (a) and positive (b) ionization modes. Spectra of the preparative 
HPTLC product, compound x, in negative (c) and positive (d) ionization modes. In accordance with literature, matching retention times and adduct 
masses for compound x, representing 7,10,13,16-Docosatetraenoylethanolamine, are shown in both ionization modes ([M–H]− = 374.26, RT: 
30.78 min; ([M + H]+  = 376.26, RT: 30.77 min), where chromatogram axis represent relative mass abundance (%) and retention time (RT, minutes), 
respectively
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pCBs, based on the reported selectivity and color index 
when developed with the fast blue B reagent. From these, 
we selected one (isolated by scraping the selected area 
from the HPTLC plate) for downstream LC–MS/MS 
analyses. The isolated compound was tentatively iden-
tified as pCB-like, with adrenoyl-EA predicted as the 
main candidate on several databases. A major limitation 
for this study is the absence of an authentic LC–MS/MS 
reference compound for adrenoyl-EA to (i) calibrate the 
instrument and accommodate for potential mass shifts/
corrections and (ii) compare fragmentation and isotope 
patterning on our instrument. Results discussed here 
are tentative based on experimental mass and database 
searches and, further investigations will be required to 
unequivocally provide evidence for the exact identity of 
compounds. These include (i) quantification and confir-
mation of compound/s with LC–MS/MS using authen-
tic standard compounds and, (ii) determining structural 
similarities and differences when compared to other 
plant-, animal- or human-derived adrenoyl-EA, with 
NMR. However, to support the idea of an alternative and 
sustainable crop to produce pCB products, it would be 
beneficial to isolate and identify the other compounds 
from the HPTLC to uncover the existence of a metabo-
lite pathway capable of producing several different pCB 
or pCB-like compounds.
Supplementary information
Supplementary information accompanies this paper at https ://doi.
org/10.1186/s1310 4-020-05372 -z.
Additional file 1: Figure S1. HPTLC phytochemical profile of Leonotis 
leonurus var. albiflora Benth. whole flower extracts, using different solvent 
concentrations for extraction. Phytochemical extractions were optimized 
using different concentrations (1, 50%; 2, 75%; 3, 100%, respectively) of 
either acetonitrile (A) or methanol (M). Mobile phase: chloroform, 10% 
methanol. Loading volume: 12 µL. pCB-specific compounds were derivat-
ized with fast blue B reagent (dissolved in 0.1%, 1 mM NaOH) under dark 
conditions. HPTLC plates were captured under visible light following 
derivatization. A single spot, based on the red–orange colour develop-
ment (A2; 75% acetonitrile extraction, indicated in the red dotted-line 
rectangle), was isolated from the HPTLC plate and used for downstream 
LC–MS/MS analyses.
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